Section: CARDIOVASCULAR
DRUG DESIGN AND DISCOVERY
Organizing Secretary: Levon M. Khachigian
NHMRC SPRF, Professor and Head
Transcription and Gene Targeting Laboratory
Centre for Vascular Research, University of New South Wales
Australia
| INVITED LECTURES
|
Abstract Awaited
Levon M. Khachigian
NHMRC SPRF, Professor and Head, Transcription and
Gene Targeting Laboratory, Centre for Vascular Research,
University of New South Wales, Australia
|
| Innovations in the development of anti-platelet
therapies for the prevention of thrombosis
Jonathan M Gibbins
School of Biological Sciences, University of Reading,
UK
|
| A pharmacological heart failure therapy
that targets nuclear pathway in cardiac myocytes
Koji Hasegawa
Director, Division of Translational Research, Kyoto
Medical Center, National Hospital Organization, Japan
|
| Signaling cardiac hypertrophy – novel
tools and mechanisms (Alternative title: Novel tools
to study cardiac hypertrophic signaling)
Stefan Engelhardt
MBP - Center for Plant Molecular Biology, ‚Eberhard
Karls University Tuebingen,‚Auf der Morgenstelle,
Tuebingen,‚Germany
|
| Development of Decoy Oligonucleotides Drug:
Innovation of Decoy Design
Ryuichi Morishita
Department of Clinical Gene Therapy, Graduate School
of Medicine, Osaka University
|
|
